Holen Sie sich die Stockscreener-App
2.60
5.45%
-0.15
Handel nachbörslich:
2.60
Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten
Published on: 2025-08-15 03:37:48 - thegnnews.com
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation - ACCESS Newswire
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Reported Earnings, And Analysts Cut Their Target Price - simplywall.st
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q2 2025 Earnings Call Transcript - Insider Monkey
Maravai LifeSciences Holdings Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
3 Promising Penny Stocks With At Least $200M Market Cap - simplywall.st
Maravai Lifesciences Holdings (MRVI) Maintains Buy Rating at RBC Capital with $5.00 Target Price - AInvest
Guggenheim Maintains Hold Rating on Maravai Lifesciences Holdings, Analyst Consensus Sees 85.92% Upside - AInvest
Maravai LifeSciences Announces Cost-Cutting Plan - 富途牛牛
RBC Capital Maintains MRVI Rating, Lowers Price Target | MRVI St - GuruFocus
Maravai LifeScience stock maintains Buy rating at Stifel despite guidance withdrawal - Investing.com Nigeria
Maravai LifeScience stock maintains Buy rating at Stifel despite guidance withdrawal By Investing.com - Investing.com South Africa
Maravai: RBC Capital Keeps Outperform, Cuts PT to $5 from $7. - AInvest
Maravai Lifesciences Announces Major Organizational Restructuring - MSN
Deutsche Bank Adjusts Maravai Lifesciences Price Target to $4.50 From $5, Maintains Buy Rating - MarketScreener
Maravai signals $50M annualized cost reduction plan as leadership targets positive EBITDA in 2026 - MSN
Maravai LifeSciences Q2 2025 Earnings Call Transcript - MarketBeat
Maravai LifeSciences Holdings Inc (MRVI) Q2 2025 Earnings Call Highlights: Navigating ... - Yahoo Finance
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Lags Revenue Estimates - MSN
Maravai LifeSciences Holdings Inc (MRVI) Q2 2025 Earnings Call Highlights: Navigating ... By GuruFocus - Investing.com Canada
Maravai Lifesciences Holdings Maintains Buy Rating with $4.25 Price Target - AInvest
Maravai LifeSciences Announces Restructuring Amid Revenue Decline - TipRanks
Maravai LifeSciences' Q2 2025: Key Contradictions in Revenue Dynamics and Strategic Outlook - AInvest
Maravai LifeSciences Reports $50M Annualized Cost Reduction Plan, Targets Positive EBITDA by 2026 - AInvest
Maravai LifeSciences Holdings, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:MRVI) - Seeking Alpha
Transcript : Maravai LifeSciences Holdings, Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener
Earnings call transcript: Maravai Lifesciences Q2 2025 sees stock dip despite revenue growth - Investing.com Nigeria
Maravai LifeSciences Cuts Costs As Revenue Slips And Guidance Paused - Finimize
Maravai Lifesciences reports Q2 adjusted EPS (8c), consensus (7c) - TipRanks
Maravai Lifesciences withdraws FY25 guidance - TipRanks
Maravai LifeSciences Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Maravai Q2 2025 slides: New leadership unveils $50M cost-cutting plan amid losses - Investing.com Canada
Maravai Q2 adjusted EPS misses estimates - MarketScreener
Maravai Lifesciences earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada
Maravai LifeSciences Announces Organizational Restructuring and Cost Reduction Initiatives Aiming for $50 Million in Annual Savings - Quiver Quantitative
Maravai LifeSciences Reports Second Quarter 2025 Financial Results - GlobeNewswire
Maravai Launches Major $50M Restructuring Plan as New CEO Takes Helm Amid Earnings Challenge - Stock Titan
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Not Doing Enough For Some Investors As Its Shares Slump 27% - simplywall.st
Sentiment analysis tools applied to Maravai LifeSciences Holdings Inc.Insider Strategy for High Conviction Picks - Newser
Stock Traders Buy Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - Defense World
Craig-Hallum Keeps Their Buy Rating on Maravai Lifesciences Holdings (MRVI) - The Globe and Mail
When is Maravai LifeSciences Holdings Inc. stock expected to show significant growthMaximize returns with strategic stock selection - Jammu Links News
How many analysts rate Maravai LifeSciences Holdings Inc. as a “Buy”Discover stocks with massive upside potential - Jammu Links News
Why is Maravai LifeSciences Holdings Inc. stock attracting strong analyst attentionHigh-yield market plays - Jammu Links News
Is Maravai LifeSciences Holdings Inc. stock overvalued or undervaluedBuild wealth steadily with smart trading - Jammu Links News
Does Maravai LifeSciences Holdings Inc. stock perform well during market downturnsFree Trend-Following Techniques - Jammu Links News
How does Maravai LifeSciences Holdings Inc. compare to its industry peersSkyrocketing profit margins - Jammu Links News
What are the latest earnings results for Maravai LifeSciences Holdings Inc.Outstanding investment returns - Jammu Links News
Is Maravai LifeSciences Holdings Inc. a growth stock or a value stockCapitalize on fast-moving market trends - Jammu Links News
Has Maravai LifeSciences Holdings Inc. found a price floorWatchlist Generator With Real-Time Entry - Newser
Pattern recognition hints at Maravai LifeSciences Holdings Inc. upsideFree Beginner Friendly Stock Selection Guide - Newser
Is Maravai LifeSciences Holdings Inc. meeting your algorithmic filter criteriaFree Swing Trading Entry Point Signals - Newser
Wells Fargo Reiterates a Buy Rating on Maravai LifeSciences Holdings (MRVI) - Insider Monkey
14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey
Price momentum metrics for Maravai LifeSciences Holdings Inc. explainedFree Capital Protection Trading Strategies - Newser
Why Maravai LifeSciences Holdings Inc. stock attracts strong analyst attention - metal.it
Published on: 2025-07-28 23:24:21 - metal.it
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025 - GlobeNewswire
Maravai LifeSciences to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 11 - Quiver Quantitative
0.11%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):